NOVAVAX, INC revenue breakdown overview

NOVAVAX, INC revenue for the last year amounted to 16.71 B MXN, the most of which — 9.03 B MXN — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 30.33 B MXN. The greatest contribution to the revenue figure was made by Europe — last year it brought NOVAVAX, INC 4.56 B MXN, and the year before that — 16.06 B MXN.